Barish Edil to Neoadjuvant Therapy
This is a "connection" page, showing publications Barish Edil has written about Neoadjuvant Therapy.
Connection Strength
0.403
-
Vaccine-Induced Intratumoral Lymphoid Aggregates Correlate with Survival Following Treatment with a Neoadjuvant and Adjuvant Vaccine in Patients with Resectable Pancreatic Adenocarcinoma. Clin Cancer Res. 2021 03 01; 27(5):1278-1286.
Score: 0.176
-
Perioperative outcomes and survival following neoadjuvant stereotactic body radiation therapy (SBRT) versus intensity-modulated radiation therapy (IMRT) in pancreatic adenocarcinoma. J Surg Oncol. 2018 Apr; 117(5):1073-1083.
Score: 0.145
-
Combination therapies for cancer: challenges and opportunities. BMC Med. 2023 05 04; 21(1):171.
Score: 0.052
-
Neoadjuvant FOLFIRINOX application in borderline resectable pancreatic adenocarcinoma: a retrospective cohort study. Medicine (Baltimore). 2014 Dec; 93(27):e198.
Score: 0.029